Inhibitory concentration (IC), IC25 and IC50 of TC-treated CCA cells.

Figshare2025-01-16 更新10

Additional file 6 of Individualized drug screening in cholangiocarcinoma using organoid models and patient-derived tumor xenograft

胆管癌药物筛选

患者来源类器官模型

Additional file 6: Table S6. The AUC of drug screening to chemotherapeutics of CCA PDOs.

Figshare2025-12-31 更新10

Table 1_Significance of mouse xenograft tumor model using patient-derived cancer organoids for clinical drug development.xlsx

胆管癌药物筛选

患者来源类器官模型

BackgroundIn vitro and in vivo preclinical examinations of cancer cell lines are performed to determine the effectiveness of new drugs before initiating clinical trials. However, there is often a sign

NIAID Data Ecosystem00

Additional file 3 of Individualized drug screening in cholangiocarcinoma using organoid models and patient-derived tumor xenograft

资源简介：

Additional file 3 of Individualized drug screening in cholangiocarcinoma using organoid models and patient-derived tumor xenograft

资源简介：

相关数据集